| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |